Notably, NEAT1 overexpression in CML cell lines (K562 and KCL22) suppresses cellular viability, enhances apoptosis, and inhibits tumour growth in xenograft models [35]. The gene discussed is NEAT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.